Cytokine expression in human cutaneous chronic graft-versus-host disease
- PMID: 8807119
Cytokine expression in human cutaneous chronic graft-versus-host disease
Abstract
Although chronic graft-versus-host disease (GVHD) remains a frequent complication of bone marrow transplantation (BMT), the pathogenesis remains unclear. We examined the potential role of cytokines in mediating chronic GVHD. Skin samples from seven patients with cutaneous chronic GVHD, six post-BMT controls and six normal controls were evaluated by reverse transcription polymerase chain reaction for the proinflammatory cytokines interleukin-1 alpha (IL-1 alpha) and tumor necrosis factor-alpha (TNF-alpha), Th1-associated cytokines IL-2 and interferon-gamma (IFN-gamma), Th2-associated cytokines IL-4, IL-5 and IL-10, and fibrosis-associated cytokines platelet derived growth factor (PDGF) and transforming growth factor-beta (TGF-beta). IFN-gamma transcription was significantly more frequent in cutaneous chronic GVHD (86%) vs post-BMT and normal controls (17% (P = 0.03) and 0 (P = 0.005), respectively). IL-2 transcription was more frequent in chronic GVHD (28%) and post-BMT controls (50%) vs normal controls (17%). TNF-alpha mRNA was frequent in chronic GVHD (71%) and post-BMT controls (83%), but not significantly more than in normal controls (50%). Transcription of IL-1alpha, IL-4, IL-5 and IL-10 was infrequent in all three groups. PDGF and TGF-beta mRNA were detected in the majority of all samples. The frequent transcription of IFN-gamma in cutaneous chronic GVHD supports its potential role in mediating the associated tissue injury. While the cellular sources of these cytokines are uncertain, their expression and secretion in situ may propagate the cytotoxic cascade and perpetuate the tissue injury. Better understanding of the contribution of FN-gamma and other cytokines to the pathogenesis of chronic GVHD may allow the design of more specific and more effective therapy.
Similar articles
-
Cytokine gene expression by concanavalin A-stimulated peripheral mononuclear cells after bone marrow transplantation: an indicator of immunological abnormality due to chronic graft-versus-host disease.Bone Marrow Transplant. 1994 Nov;14(5):695-701. Bone Marrow Transplant. 1994. PMID: 7889002
-
Serum cytokine levels in bone marrow transplantation: synergistic interaction of interleukin-6, interferon-gamma, and tumor necrosis factor-alpha in graft-versus-host disease.Bone Marrow Transplant. 1994 Jun;13(6):745-51. Bone Marrow Transplant. 1994. PMID: 7920309
-
IL-2 inhibits early increases in serum gamma interferon levels associated with graft-versus-host-disease.Transplantation. 1994 Dec 27;58(12):1385-93. Transplantation. 1994. PMID: 7809932
-
Cytokines involved in graft-versus-host disease.Hokkaido Igaku Zasshi. 1994 Nov;69(6):1348-53. Hokkaido Igaku Zasshi. 1994. PMID: 7705747 Review.
-
Cytokine gene expression after allogeneic bone marrow transplantation.Leuk Lymphoma. 1995 Feb;16(5-6):413-8. doi: 10.3109/10428199509054427. Leuk Lymphoma. 1995. PMID: 7787751 Review.
Cited by
-
Novel pre-clinical mouse models for chronic Graft-versus-Host Disease.Front Immunol. 2023 Jan 24;13:1079921. doi: 10.3389/fimmu.2022.1079921. eCollection 2022. Front Immunol. 2023. PMID: 36761159 Free PMC article.
-
The kinetics of mRNA transforming growth factor beta1 expression and its serum concentration in graft-versus-host disease after allogeneic hemopoietic stem cell transplantation for myeloid leukemias.Med Sci Monit. 2011 Jun;17(6):CR322-8. doi: 10.12659/msm.881804. Med Sci Monit. 2011. PMID: 21629186 Free PMC article.
-
Rippled skin, fasciitis, and joint contractures.J Am Acad Dermatol. 2008 Dec;59(6):1070-4. doi: 10.1016/j.jaad.2008.08.023. J Am Acad Dermatol. 2008. PMID: 19022104 Free PMC article. No abstract available.
-
Biomarkers in chronic graft-versus-host disease.Expert Rev Hematol. 2011 Jun;4(3):329-42. doi: 10.1586/ehm.11.27. Expert Rev Hematol. 2011. PMID: 21668397 Free PMC article. Review.
-
The isomorphic response in morphealike chronic graft-vs-host disease.Arch Dermatol. 2008 Sep;144(9):1229-31. doi: 10.1001/archderm.144.9.1229. Arch Dermatol. 2008. PMID: 18794477 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical
Miscellaneous